168 related articles for article (PubMed ID: 7732513)
1. Decreased counterregulatory hormone responses to insulin-induced hypoglycemia in patients with pancreatic diabetes having autonomic neuropathy.
Nakamura T; Takebe K; Kudoh K; Ishii M; Imamura K; Kikuchi H; Kasai F; Tandoh Y; Yamada N; Arai Y
Tohoku J Exp Med; 1994 Dec; 174(4):305-15. PubMed ID: 7732513
[TBL] [Abstract][Full Text] [Related]
2. Epinephrine secretion, hypoglycemia unawareness, and diabetic autonomic neuropathy.
Hoeldtke RD; Boden G
Ann Intern Med; 1994 Mar; 120(6):512-7. PubMed ID: 8311375
[TBL] [Abstract][Full Text] [Related]
3. The significance of impaired pancreatic polypeptide and epinephrine responses to hypoglycemia in patients with insulin-dependent diabetes mellitus.
Kennedy FP; Bolli GB; Go VL; Cryer PE; Gerich JE
J Clin Endocrinol Metab; 1987 Mar; 64(3):602-8. PubMed ID: 3818892
[TBL] [Abstract][Full Text] [Related]
4. Clinical and hormonal aspects of pancreatic diabetes.
Bank S; Marks IN; Vinik AI
Am J Gastroenterol; 1975 Jul; 64(1):13-22. PubMed ID: 808121
[TBL] [Abstract][Full Text] [Related]
5. Reduced epinephrine secretion and hypoglycemia unawareness in diabetic autonomic neuropathy.
Hoeldtke RD; Boden G; Shuman CR; Owen OE
Ann Intern Med; 1982 Apr; 96(4):459-62. PubMed ID: 7065562
[TBL] [Abstract][Full Text] [Related]
6. Abnormal glucose counterregulation in insulin-dependent diabetes mellitus. Interaction of anti-insulin antibodies and impaired glucagon and epinephrine secretion.
Bolli G; de Feo P; Compagnucci P; Cartechini MG; Angeletti G; Santeusanio F; Brunetti P; Gerich JE
Diabetes; 1983 Feb; 32(2):134-41. PubMed ID: 6337896
[TBL] [Abstract][Full Text] [Related]
7. Glucagon response to hypoglycemia in diabetic neuropathy.
Maher TD
Horm Metab Res Suppl; 1980; 9():87-9. PubMed ID: 6929783
[TBL] [Abstract][Full Text] [Related]
8. Impaired counter regulation of hypoglycemia in a group of insulin-dependent diabetics with recurrent episodes of severe hypoglycemia.
Adamson U; Lins PE; Efendic S; Hamberger B; Wajngot A
Acta Med Scand; 1984; 216(2):215-22. PubMed ID: 6388251
[TBL] [Abstract][Full Text] [Related]
9. Long-term intensive therapy of IDDM patients with clinically overt autonomic neuropathy: effects on hypoglycemia awareness and counterregulation.
Fanelli C; Pampanelli S; Lalli C; Del Sindaco P; Ciofetta M; Lepore M; Porcellati F; Bottini P; Di Vincenzo A; Brunetti P; Bolli GB
Diabetes; 1997 Jul; 46(7):1172-81. PubMed ID: 9200653
[TBL] [Abstract][Full Text] [Related]
10. Relevance of glucose counterregulatory systems to patients with diabetes: critical roles of glucagon and epinephrine.
Cryer PE; Gerich JE
Diabetes Care; 1983; 6(1):95-9. PubMed ID: 6341018
[TBL] [Abstract][Full Text] [Related]
11. Effects of autonomic neuropathy on counterregulation and awareness of hypoglycemia in type 1 diabetic patients.
Meyer C; Grossmann R; Mitrakou A; Mahler R; Veneman T; Gerich J; Bretzel RG
Diabetes Care; 1998 Nov; 21(11):1960-6. PubMed ID: 9802751
[TBL] [Abstract][Full Text] [Related]
12. Differential regulation of counterregulatory hormone secretion and symptoms during hypoglycemia in IDDM. Effect of glycemic control.
Kinsley BT; Widom B; Simonson DC
Diabetes Care; 1995 Jan; 18(1):17-26. PubMed ID: 7698043
[TBL] [Abstract][Full Text] [Related]
13. Intermittent hypoglycemia impairs glucose counterregulation.
Widom B; Simonson DC
Diabetes; 1992 Dec; 41(12):1597-602. PubMed ID: 1446801
[TBL] [Abstract][Full Text] [Related]
14. Subnormal pancreatic polypeptide and epinephrine responses to insulin-induced hypoglycemia identify patients with insulin-dependent diabetes mellitus predisposed to develop overt autonomic neuropathy.
Kennedy FP; Go VL; Cryer PE; Bolli GB; Gerich JE
Ann Intern Med; 1988 Jan; 108(1):54-8. PubMed ID: 3276265
[TBL] [Abstract][Full Text] [Related]
15. [Glucagon, growth hormone, and cortisol response to insulin-induced hypoglycemia in insulin-dependent diabetics (IDD) without autonomic neuropathy (author's transl)].
Drost H; Grüneklee D; Kley HK; Wiegelmann W; Krüskemper HL; Gries FA
Klin Wochenschr; 1980 Nov; 58(21):1197-205. PubMed ID: 7005532
[TBL] [Abstract][Full Text] [Related]
16. Somatostatin and counterregulatory hormone responses to hypoglycaemia in diabetics with and without autonomic neuropathy.
Fernandez-Castaner M; Webb S; Levy I; Rios M; Casamitjana R; Bergua M; Figuerola D; Rivera F
Diabete Metab; 1985 Apr; 11(2):81-6. PubMed ID: 2861121
[TBL] [Abstract][Full Text] [Related]
17. Diabetes mellitus secondary to chronic pancreatitis.
Larsen S
Dan Med Bull; 1993 Apr; 40(2):153-62. PubMed ID: 8495594
[TBL] [Abstract][Full Text] [Related]
18. Troglitazone amplifies counterregulatory responses to hypoglycemia in nondiabetic subjects.
Gabriely I; Wozniak R; Hawkins M; Shamoon H
J Clin Endocrinol Metab; 2001 Feb; 86(2):521-8. PubMed ID: 11158003
[TBL] [Abstract][Full Text] [Related]
19. Lack of glucagon response to hypoglycemia in diabetic autonomic neuropathy.
Maher TD; Tanenberg RJ; Greenberg BZ; Hoffman JE; Doe RP; Goetz FC
Diabetes; 1977 Mar; 26(3):196-200. PubMed ID: 838171
[TBL] [Abstract][Full Text] [Related]
20. Effects of acute sodium salicylate on the abnormal counterregulatory glucagon and epinephrine responses to insulin hypoglycemia in diabetic rats.
Patel DG
Life Sci; 1989; 44(4):301-10. PubMed ID: 2644509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
